New hope for men battling hot flashes from prostate cancer treatment
NCT ID NCT07568236
First seen May 06, 2026 · Last updated May 06, 2026
Summary
This study tests a drug called fezolinetant to see if it can reduce hot flashes in men receiving hormone therapy for prostate cancer. About 54 men will be randomly assigned to receive either the drug or a placebo. The main goal is to measure how often and how severe hot flashes are, and how they affect quality of life and sleep.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Prince of Wales Hospital
Shatin, Hong Kong
Conditions
Explore the condition pages connected to this study.